Abstract:Objective To verify whether microRNA-599 (miR-599) could inhibit vascular smooth muscle cell (VSMC) dedifferentiation by targeting platelet-derived growth factor-BB(PDGF-BB) in varicose veins. Methods Varicose veins and normal samples were collected from patients undergoing great saphenous vein transplantation surgery. qRT-PCR was used to test the expressions of miR-599, miR-200, miR-145, miR-146b and miR-155 in the varicose veins. Western blot was used to test the expressions of SM-actin, SM-22, SM-MCH and OPN. For in vitro experiment, after miR-599 was transfected into VSMCs, MTT was used to investigate the proliferation ability of VSMCs, wound healing was employed to test the migratory ability of VSMCs, Western blot was used to investigate the expressions of SM-actin, SM-22, SM-MHC, OPN and PDGF-BB in VSMCs. Luciferase assay was used to confirm whether PDGF-3'-UTR was the target gene of miR-599. Results Compared with the healthy control tissue, the expressions of miR-599, SM-actin, SM-22 and SM-MHC in the varicose veins were significantly decreased (P < 0.05); meanwhile the expression of OPN increased (P < 0.01). The result of the in vitro experiment showed that compared with the control group, the expressions of SM-actin, SM-22 and SM-MHC were increased in the miR-599 group (P < 0.05), and the expression of OPN and PDGF-BB decreased (P < 0.05). The luciferase activity of the PDGF-3'-UTR plasmid was suppressed by miR-599 (P < 0.05). Conclusions In varicose veins, the expression of miR-599 decreases. miR-599 inhibits VSMC dedifferentiation by targeting PDGF-3'-UTR.